Sofia Lindqvist
Sofia covers sector rotation and thematic flows across small- and mid-cap equities, including energy, industrials, and the AI infrastructure supply chain.
Articles by Sofia Lindqvist
Small Caps Enter the Sept. 16 Fed Decision Carrying the Market's Most Floating-Rate Balance Sheets
The FOMC meets Tuesday and Wednesday with futures markets pricing a quarter-point increase, and the Russell 2000's debt structure makes it the most exposed cohort in US equities. What the projections say may matter more than the 25 basis points.
Tariff refunds are making some consumer gross margins unreadable, and Lovesac's Thursday print is the cleanest example yet
Lovesac reported a 1,200 basis point jump in second-quarter gross margin and swung to a GAAP profit while its adjusted EBITDA turned negative — a divergence driven by roughly $21.0 million of IEEPA tariff refunds and interest, $20.0 million of which ran through cost of merchandise sold. Oxford Industries and YETI have posted the same distortion at different magnitudes, and each has drawn the GAAP-versus-adjusted line in a different place.
UNFI ends fiscal 2026 with adjusted EBITDA up 27% as net sales fall 2%
The grocery wholesaler beat consensus on fourth-quarter adjusted earnings but came in light on revenue, then set a fiscal 2027 sales range below the analyst estimate while approving a new $200m buyback.
American Healthcare REIT Buys Eight East Coast Senior Housing Communities for About $696 Million
The 867-unit portfolio was built between 2020 and 2022 and will be run almost entirely by LCB Senior Living. The purchase pushes the REIT's disclosed 2026 investment total past $2 billion.
Scholar Rock Wins FDA Fast Track and Orphan Drug Status for Apitegromab in FSHD as Phase 2 Dosing Begins
The designations open a second indication for the myostatin inhibitor four weeks before its Sept. 30 FDA action date in spinal muscular atrophy. The company had $492.1 million of cash at June 30 and is not yet profitable.
Solstice and Element Solutions Call Off $14.5 Billion Merger as Solstice Authorizes $500 Million Buyback
The two advanced-materials companies mutually terminated the cash-and-stock combination announced in July, with no fees payable by either side despite reciprocal break fees written into the agreement. Solstice cited conversations with shareholders, authorized a new $500 million buyback and reaffirmed its 2026 outlook.
SuperX Announced a $38.8 Million Nvidia Server Order. Its Last Reported Period Showed $2.83 Million of Revenue.
The Nasdaq-listed AI server assembler keeps disclosing Japanese orders far larger than anything that has reached its income statement. The distance between bookings and recognized revenue is the entire question.
OSI Systems posts record cash flow and a record backlog, then loses more than a tenth of its value. The problem was the top line and the fiscal 2027 outlook, not the earnings line.
The airport-scanner and optoelectronics maker reported fiscal fourth-quarter revenue of $484.1 million, down 4% year over year and about 8.5% short of the $529 million analysts expected, according to StockStory. Non-GAAP earnings per share of $3.78 were essentially in line, and fiscal 2027 non-GAAP EPS guidance of $11.13 to $11.49 brackets a midpoint slightly below consensus.
Ultragenyx Faces Two Gene-Therapy Decision Dates 27 Days Apart, One a Re-Run of a Manufacturing Rejection
The FDA has set target action dates of August 23 and September 19, 2026 for two of Ultragenyx's AAV gene therapies. The second is a resubmission after a July 2025 Complete Response Letter that the company says cited chemistry, manufacturing and controls issues only, with no review issues flagged on the clinical data package. Ultragenyx reported $436 million in cash, equivalents and marketable securities at June 30, 2026, against $214 million of quarterly revenue. Both goal dates fall on a weekend.
KinderCare Fell 46% in a Session. The Subsidy Story Behind It Is Not the One That Circulated
KLC closed at $2.60 on Friday, down 46.17%, after cutting 2026 guidance. But the company never said subsidy rates were reduced — its CFO said increases were arriving more slowly than expected, and more than half the EBITDA guidance cut was an insurance actuarial item.
Three Weeks That Repriced September — and the Fed Minutes That Could Reprice Them Back
The Russell 2000 closed Friday at a record 3,068.42 and led every major index for the week, as market-implied odds of a September rate hike fell from roughly two-thirds in late July to a range of 24% to just above 30% by Friday, depending on which venue and which hour you ask. Wednesday at 2:00 p.m. ET brings the first look inside the July 28-29 meeting, where three officials dissented in favor of raising rates — the first triple same-direction dissent since September 2016. The minutes will not say how the Fed reads this month's data, because the meeting predates all of it.
Applied Optoelectronics Gained 15% on Friday With No Identified Company Catalyst. The Filings Explain What the Tape Did Not.
AAOI closed at $150.28 in a session that trackers could not pin to a same-day catalyst, so we went back to the quarter and the 10-Q: record revenue, a widening GAAP loss, three customers supplying nearly all of it, and a $12.7 billion market value that no longer belongs to a small cap.
Schedule Risk Comes Due: Virgin Galactic Slips to 2027, Spire's Margin Cracks, and Intuitive Machines Misses on a Record Quarter
Two small-cap space companies reported after Wednesday's close and both fell in extended trading, one on a four-month delay and one on a gross margin that dropped 16 points. Intuitive Machines reported Thursday morning with revenue more than four times year-ago levels, a record $1.76 billion backlog — and a miss on both lines.